997
Participants
Start Date
December 13, 2018
Primary Completion Date
February 28, 2023
Study Completion Date
August 27, 2024
Tislelizumab
200 mg intravenously (IV) on Day 1 of each 21-day cycle
Placebo
Placebo to match tislelizumab IV on Day 1 of each 21-day cycle
Cisplatin
80 mg/m² IV on Day 1 of each 21-day cycle
Oxaliplatin
130 mg/m² IV on Day 1 of each 21-day cycle
Capecitabine
1000 mg/m² orally twice daily (BD) Days 1 through 14 (14 days total) of each 21-day cycle
5-Fluorouracil
800 mg/m²/day IV using continuous infusion on Days 1 to 5 of each 21-day cycle
Azienda Ospedaliera Universitaria Policlinico Tor Vergata, Roma
National Cheng Kung University Hospital, Tainan City
Kaohsiung Medical University Chung Ho Memorial Hospital, Kaohsiung City
Hospital General Universitario de Elche, Elche
Chung Ang University Hospital, Seoul
Hospital Clinic de Barcelona, Barcelona
Azienda Ospedaliera Citta Della Salute E Della Scienza Di Torino, Torino
National Cancer Center, Goyang-si
Taipei Veterans General Hospital, Taipei
Hopital de La Timone, Marseille
Seoul National University Bundang Hospital, Seongnam-si
The Catholic University of Korea, St Vincents Hospital, Suwon
Ajou University Hospital, Suwon
Fox Chase Cancer Center, Philadelphia
Reading Hospital, West Reading
Fondazione Irccs Istituto Nazionale Dei Tumori, Milan
Centre Georges Francois Leclerc, Dijon
Dicle University Medical Faculty, Diyarbakır
Chu Besancon Hopital Jean Minjoz, Doubs
Hopital Nord Franche Comte Site Du Mittan, Montbéliard
Hospital General Universitario Gregorio Maranon, Madrid
Hospital Universitario La Paz, Madrid
Hospital Universitario Hm Madrid Sanchinarro, Madrid
Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda
Hospital Regional Universitario de Malaga, Málaga
Southeastern Regional Medical Center, Newnan
Complejo Hospitalario de Navarra, Pamplona
Chu Bordeaux Hopital Haut Leveque, Pessac
Iu C, Clinical Research Excellence Application and Research Center, Stanbul
Iov Istituto Oncologico Veneto Irccs, Padua
Tennessee Oncology, Pllc Nashville, Nashville
Azienda Ospedaliera Universitaria Policlinico Santorsola Malpighi, Bologna
Hospital Universitario Virgen Del Rocio, Seville
Kyungpook National University Chilgok Hospital, Daegu
Ohio State University Hospital, Columbus
Nonu Universitesi Tip Fakultesi, Battalgazi
Hospital Clinico Universitario de Valencia, Valencia
Initia Oncologia, Slp, Valencia
Hospital de Basurto, Bilbao
Hospital Universitario Miguel Servet, Zaragoza
Aou Senese Policlinico Santa Maria Alle Scotte, Siena
Icl Alexis Vautrin, Meurthe Et Moselle
Azienda Ospedaliero Universitaria Pisana, Pisa
Chonnam National University Hwasun Hospital, HwasunGun
Namik Kemal University, Tekirdağ
Azienda Ospedaliera Universitaria Delle Marche, Torrette
Karadeniz Tecnical Uni Med Fac, Trabzon
Ao Ospedali Riuniti Marche Nord, Pesaro
Irccs Ospedale Casa Sollievo Della Sofferenza, San Giovanni Rotondo
Istituto Nazionale Tumori Fondazione G Pascale, Napoli
University of California Davis Health System, Sacramento
Peking University Third Hospital, Beijing
Beijing Chao Yang Hospital, Beijing
Cancer Hospital Chinese Academy of Medical Sciences, Beijing
Beijing Friendship Hospital, Capital Medical University, Beijing
Beijing Cancer Hospital, Beijing
Peking Union Medical College Hospital, Beijing
Chinese Pla General Hospital, Beijing
Beijing Luhe Hospital, Capital Medical University, Beijing
The First Hospital of China Medical University, Shenyang
The General Hospital of Shenyang Military, Shenyang
Liaoning Cancer Hospital and Institute, Shenyang
Vitamed Llc, Moscow
The First Hospital of Jilin University, Changchun
Harbin Medical University Cancer Hospital, Harbin
Sbih of Yaroslavl Region Regional Clinical Oncological Hospital, Yaroslavl
Rbih Ivanovo Regional Oncological Dispensary, Ivanovo
Arkhangelsk Regional Clinical Oncological Dispensary, Arkhangelsk
Pavlov First Saint Petersburg State Medical University, SaintPetersburg
Fsbi Clinical Research and Practical Center For Specialized Medical Care (Oncology), SanktPetersburg
Rui Jin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai
Affiliated Zhongshan Hospital of Fudan University, Shanghai
Shanghai General Hospital, Shanghai
Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai
Nanjing Drum Tower Hospital,the Affiliated Hospital of Nanjing University Medical School, Nanjing
Nantong Tumor Hospital Branch South, Nantong
Anhui Provincial Cancer Hospital Aka West Branch of Anhui Province Hospital, Hefei
The Second Hospital of Anhui Medical University, Hefei
The First Affiliated Hospital of Bengbu Medical College, Bengbu
Shandong Cancer Hospital, Jinan
The Affiliated Hospital of Qingdao University Branch South, Qingdao
Linyi Cancer Hospital, Linyi
Tianjin Medical University General Hospital, Tianjin
Tianjin Medical University Cancer Institute and Hospital, Tianjin
The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
Zhejiang University College of Medicine Second Affiliated Hospital, Hangzhou
Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou
Zhejiang Cancer Hospital, Hangzhou
The Second Affiliated Hospital of Nanchang University, Nanchang
The First Affiliated Hospital of Fujian Medical University, Fuzhou
Fujian Cancer Hospital, Fuzhou
Daping Hospital, Third Military Medical University, Chongqing
State Budgetary Healthcare Institution Volgograd Regional Clinical Oncology Dispensary, Volgograd
Xiangya Hospital of Central South University, Changsha
Hunan Cancer Hospital, Changsha
Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan
Hubei Cancer Hospital, Wuhan
Private Educational Institution of Higher Education Medical University Reaviz, Samara
Henan Cancer Hospital, Zhengzhou
Henan Provincial Peoples Hospital, Zhengzhou
The First Affiliated Hospital of Zhengzhou University, Zhengzhou
Sun Yat Sen University Cancer Center, Guangzhou
Guangdong Provincial Peoples Hospital, Guangzhou
Shenzhen Peoples Hospital, Shenzhen
Foshan First Peoples Hospital, Foshan
Affiliated Hospital of Guilin Medical University, Guilin
Hainan General Hospital, Haikou
Sbhi of Novosibirsk Region Novosibirsk Regional Oncological Dispensary, Novosibirsk
Bih of Omsk Region Clinical Oncology Dispensary, Omsk
Yunnan Cancer Hospital, Kunming
The First Hospital of Lanzhou University, Lanzhou
The Fourth Hospital of Hebei Medical University, Shijiazhuang
Centre Antoine Lacassagne, Nice
Chiba Cancer Center, Chiba
Tesshokai Kameda General Hospital, Kamogawashi
Nho Shikoku Cancer Center, Matsuyama
Nho Kyushu Cancer Center, Fukuoka
Gunma Prefectural Cancer Center, Otashi
Hokkaido University Hospital, Sapporo
Johas Kansai Rosai Hospital, Amagasakishi
Ishikawa Prefectural Central Hospital, Kanazawa
Kagawa University Hospital, Kitagun
Kanagawa Cancer Center, Yokohama
Oita University Hospital, Yufushi
Kurashiki Central Hospital, Kurashikishi
Okayama University Hospital, Okayama
Izumi City General Hospital, Izumishi
Nho Osaka National Hospital, Osakashi
Osaka University Hospital, Suitashi
Saitama Medical University International Medical Center, Hidakashi
Saitama Cancer Center, Kitaadachigun
Hamamatsu University School of Medicine, University Hospital, Hamamatsushi
National Cancer Center Hospital, Chuoku
Tokyo Metropolitan Tama Medical Center, Fuchushi
Cancer Institute Hospital of Jfcr, Kotoku
Center Hospital of the National Center For Global Health and Medicine, Shinjukuku
Uniwersyteckie Centrum Kliniczne, Gdansk
Centrum Terapii Wspolczesnej Jm Jasnorzewska Sp Komandytowo Akcyjna, Lodz
Przychodnia Med Polonia Sp Z Oo, Poznan
Narodowy Instytut Onkologii Im Marii Skodowskiej Curie Pastwowy Instytut Badawczy, Warsaw
Pan American Oncology Trials, Llc, Rio Piedras
Seoul National University Hospital, Seoul
Severance Hospital Yonsei University Health System, Seoul
Asan Medical Center, Seoul
Acibadem Adana Hospital, Adana
Dr Abdurrahman Yurtaslan Oncology Teaching and Research Hospital, Ankara
Akdeniz University Hospital, Konyaalt
Velindre Cancer Centre, Cardiff
Sarah Cannon Research Institute Uk, London
Lead Sponsor
BeiGene
INDUSTRY